Malic Acid

Malic Acid

SCHEMBL733142

O=C(O)CC(O)C(=O)O.[KH].[KH]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDRD2HTR1BHTR1DHTR1F

The experimentally established mechanism targets of Malic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.94
SLC22A6 Q4U2R8 1/20 0.53
TET2 Q6N021 6/20 0.52
TET3 O43151 2/20 0.52
TET1 Q8NFU7 1/20 0.52
KDM4A O75164 2/20 0.50
KDM4C Q9H3R0 2/20 0.50
KDM2A Q9Y2K7 2/20 0.50
OR51E2 Q9H255 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
GABRR1 P24046 2/20 0.43
LMNA P02545 1/20 0.43
KMO O15229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malic Acid SCHEMBL29008105 1.00 SMN1; SMN2 (0.94) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL95333 1.00 SMN1; SMN2 (0.94) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL20339816 1.00 SMN1; SMN2 (0.94) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL11502487 0.97 SMN1; SMN2 (0.88) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL10524028 0.97 SMN1; SMN2 (0.88) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL9478094 0.97 SMN1; SMN2 (0.88) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL5427117 0.97 SMN1; SMN2 (0.88) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL29008345 0.97 SMN1; SMN2 (0.88) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL856 0.97
Malic Acid SCHEMBL14125844 0.97 SMN1; SMN2 (1.00) SMN1; SMN2SLC22A6TET2TET3TET1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014404-A1 LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME PERIMETER SOLUTIONS, LP (US) 2026-01-15 US claimed
WO-2025264733-A1 LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME PERIMETER SOLUTIONS, LP (US) 2025-12-26 WO claimed
CN-114436812-B Preparation method of dipotassium malate 河南瑞贝佳生物科技有限公司 2024-07-16 CN claimed
CN-118064905-A Electrolyte modification and electrolyte for prolonging service life of alkaline electrolyzed seawater electrode and application 中国科学院大连化学物理研究所 2024-05-24 CN claimed
WO-2023191907-A1 LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME FRS GROUP, LLC (US) 2023-10-05 WO claimed
CN-116669434-A Tin oxide electron transport layer modified in situ by aliphatic carboxylic acid potassium salt, high-performance photovoltaic cell and preparation method thereof 武汉理工大学 2023-08-29 CN claimed
CN-114436812-A Preparation method of dipotassium malate 河南瑞贝佳生物科技有限公司 2022-05-06 CN claimed
US-8420151-B2 Mixtures having a salty taste SYMRISE AG (DE) 2013-04-16 US claimed
WO-2012143794-A1 POLYMER STABILIZER SYSTEM FOR POLYMERS CONTAINING HALOGEN GALATA CHEMICALS GMBH (DE) 2012-10-26 WO claimed
EP-1937089-B1 MIXTURES HAVING A SALTY TASTE SYMRISE AG (DE) 2012-08-22 EP claimed
US-20090214728-A1 MIXTURES HAVING A SALTY TASTE SYMRISE GMBH & CO. KG (DE) 2009-08-27 US claimed
US-20080260948-A1 INK AND INK JET RECORDING METHOD CANON KABUSHIKI KAISHA (JP) 2008-10-23 US claimed
EP-1937089-A1 MIXTURES HAVING A SALTY TASTE Symrise GmbH & Co. KG (DE) 2008-07-02 EP claimed
WO-2007045566-A1 MIXTURES HAVING A SALTY TASTE SYMRISE GMBH & CO. KG (DE) 2007-04-26 WO claimed
US-5895525-A ALKALI METAL MALATE OR CITRAMALATE SALT ACCELERATOR AND CALCIUM ALUMINUM SILICATE HYDRAULIC CEMENT; SHOTCRETING MBT HOLDING AG (CH) 1999-04-20 US claimed
US-5591259-A MIXING WITH MALATE OR CITRAMALATE ACCELERATOR SANDOZ LTD. (CH) 1997-01-07 US claimed
WO-2026105439-A1 LEATHER SURFACE TREATMENT AGENT AND LEATHER TREATED USING SAME 日華化学株式会社 2026-05-21 WO disclosed
WO-2026098867-A1 OXIDATIVE HAIR BRIGHTENING BY MEANS OF PERSULFATE, DICARBOXYLIC ACID, AND CITRULLINE HENKEL AG & CO. KGAA (DE) 2026-05-15 WO disclosed
US-4460723-A STABILIZATION WITH ACID SALTS ALONE AND WITH RUBBER ADDITIONS PHILLIPS PETROLEUM COMPANY (US) 1984-07-17 US disclosed
US-4330484-A Diastereomeric salts of malic acid and 2-aminobutanol, and process for the resolution of rademis maic acid BASF AKTIENGESELLSCHAFT (DE) 1982-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260014404-A1 LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME SLC6A12, SLC11A2, KCNN1 SMN1; SMN2 2997/4885SLC22A6 274/4885TET2 1451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.